Bi-Coastal Pharma International
FDA inspection history in Shrewsbury, New Jersey, 2022
- 1
- Form 483
Every document, by year
- Form 483
2022: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2022One Form 483, at Shrewsbury, New Jersey.
Cited most
Across all Bi-Coastal Pharma International observations on file
- 21 CFR 211.22Responsibilities of quality control unit1
The complete Bi-Coastal Pharma International file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Shrewsbury, New Jersey
One Form 483 · 2022 · 1 observation
Latest: Form 483, Jan 14, 2022 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2022-01-14 | 483 Form 483 | Shrewsbury, New Jersey | 1 | $99 |
Investigators on these documents
About Bi-Coastal Pharma International
How many FDA Form 483s has Bi-Coastal Pharma International received?
FDA Intel has 1 Form 483 on file for Bi-Coastal Pharma International; the most recent is dated Jan 14, 2022.
When was Bi-Coastal Pharma International last inspected by FDA?
The most recent FDA inspection document on file for Bi-Coastal Pharma International is a Form 483 dated Jan 14, 2022, for the site in Shrewsbury, New Jersey.
What did FDA cite at Bi-Coastal Pharma International?
The regulations cited most in the observations on file for Bi-Coastal Pharma International are 21 CFR 211.22 (Responsibilities of quality control unit), 1 time.